- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Aspira Pathlab & Diagnostics Ltd (ASPR)
Aspira Pathlab & Diagnostics Ltd stock price live, this page displays BO ASPR stock exchange data. View the ASPR premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Aspira Pathlab & Diagnostics Ltd real time stock price chart below.
What Is the Aspira Pathlab & Diagnostics Ltd Stock Price Today?
The Aspira Pathlab & Diagnostics Ltd stock price today is 62.70.
What Is the Stock Symbol for Aspira Pathlab & Diagnostics Ltd?
The stock symbol for Aspira Pathlab & Diagnostics Ltd is ""ASPR.""
What Stock Exchange Does Aspira Pathlab & Diagnostics Ltd Trade On?
Aspira Pathlab & Diagnostics Ltd is listed and trades on the BSE stock exchange.
Is Aspira Pathlab & Diagnostics Ltd a Good Stock to Buy?
Determining whether Aspira Pathlab & Diagnostics Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ASPR quote. (ISIN: INE500C01017)
What Is the Aspira Pathlab & Diagnostics Ltd Stock Price Today?
The Aspira Pathlab & Diagnostics Ltd stock price today is 62.70.
What Is the Stock Symbol for Aspira Pathlab & Diagnostics Ltd?
The stock symbol for Aspira Pathlab & Diagnostics Ltd is ""ASPR.""
What Stock Exchange Does Aspira Pathlab & Diagnostics Ltd Trade On?
Aspira Pathlab & Diagnostics Ltd is listed and trades on the BSE stock exchange.
Is Aspira Pathlab & Diagnostics Ltd a Good Stock to Buy?
Determining whether Aspira Pathlab & Diagnostics Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ASPR quote. (ISIN: INE500C01017)
BSE
Currency in INR
62.70
+0.01(+0.02%)
Closed·
Fair Value
An estimate of a Aspira Pathlab's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
62.69
62.70
52 wk Range
30.00
106.78
ASPR Scorecard
Full Analysis
Stock has taken a big hit over the last week
ASPR is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Aspira Pathlab's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
62.6962.70
52 wk Range
30.00106.78
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
ASPR Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Aspira Pathlab's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low P/E ratio relative to near-term earnings growth
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Buy
Aspira Pathlab & Diagnostics Ltd Company Profile
Aspira Pathlab & Diagnostics Limited owns, manages, runs, and administers various diagnostics centers primarily in India. It offers biochemistry, hematology, histopathology, microbiology, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigation services. The company was formerly known as Utkal Soap Products Limited and changed its name to Aspira Pathlab & Diagnostics Limited in November 2016. Aspira Pathlab & Diagnostics Limited was incorporated in 1973 and is based in Mumbai, India.
Compare ASPR to Peers and Sector
Metrics to compare | ASPR | Peers Peers - average of corresponding metrics from companies closely matching ASPR: MAITREYA, 536565, 540797, MONOPHARMA, 531099 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipASPRPeersSector |
|---|---|---|---|---|
P/E Ratio | 31.9x | 19.9x | −0.5x | |
PEG Ratio | 0.18 | 0.08 | 0.00 | |
Price/Book | 5.3x | 1.7x | 2.6x | |
Price / LTM Sales | 2.9x | 1.8x | 3.3x | |
Upside (Analyst Target) | - | 52.6% | 43.4% | |
Fair Value Upside | Unlock | 8.9% | 7.1% | Unlock |
Earnings
Latest Release
May 16, 2025
EPS / Forecast
0.66 / --
Revenue / Forecast
59.07M / --
People Also Watch
FAQ
What Stock Exchange Does Aspira Pathlab Trade On?
Aspira Pathlab is listed and trades on the Bombay Stock Exchange stock exchange.
What Is the Stock Symbol for Aspira Pathlab?
The stock symbol for Aspira Pathlab is "ASPR."
What Is the Aspira Pathlab Market Cap?
As of today, Aspira Pathlab market cap is 645.37M.
What Is Aspira Pathlab's Earnings Per Share (TTM)?
The Aspira Pathlab EPS (TTM) is 1.97.
From a Technical Analysis Perspective, Is ASPR a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Aspira Pathlab Stock Split?
Aspira Pathlab has split 0 times.
How Many Employees Does Aspira Pathlab Have?
Aspira Pathlab has 0 employees.
What is the current trading status of Aspira Pathlab (ASPR)?
As of 08 Aug 2025, Aspira Pathlab (ASPR) is trading at a price of 62.70, with a previous close of 62.69. The stock has fluctuated within a day range of 62.69 to 62.70, while its 52-week range spans from 30.00 to 106.78.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.